<DOC>
	<DOC>NCT02452684</DOC>
	<brief_summary>To investigate the safety and efficacy of administration of eszopiclone for 4 weeks in insomnia patients.</brief_summary>
	<brief_title>Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>1. Insomnia participants who did not take eszopiclone before assessment 2. Participants who receive assessment by using sleep questionaries</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Insomnia</keyword>
</DOC>